Amalia Dolga is an associate professor and a Rosalind Franklin Fellow at the University of Groningen, the Netherlands. Dr. Dolga earned her PhD at the Rijksuniversiteit Groningen in The Netherlands, where she studied the molecular mechanisms of neurodegeneration, with a focus on TNF signaling. She undertook postdoctoral training at the University of Marburg, Germany, where she demonstrated the functional relevance of calcium-activated potassium channels in several models of neurodegeneration. In 2015, she obtained the ‘Habilitation’ and received the Rosalind Franklin fellowship, allowing her to start her own research group in neuroscience at the Groningen Research Institute of Pharmacy in Groningen (GRIP), the Netherlands. Her laboratory aims to identify the molecular mechanisms responsible for cell death and elucidate their involvement in neurodegeneration, particularly in Parkinson’s disease. To achieve this goal, her lab conducts pharmacological, genetic, biochemical and physiological studies of mitochondrial functions and inflammation in human cells.